| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kardis Phillip John II | President and CEO, Director | C/O: CHIMERA INVESTMENT CORPORATION, 630 FIFTH AVENUE, SUITE 2400, NEW YORK | /s/ Phillip John Kardis II | 2025-12-02 | 0001652530 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CIM | Common Stock | Tax liability | -$1.32M | -103K | -20.71% | $12.79 | 394K | 01 Dec 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Shares reported were withheld for payment of taxes associated with the settlement of deferred shares of Chimera Investment Corporation ("Chimera") common stock from the vesting of prior grants of performance stock units ("PSUs") and restricted stock units ("RSUs") pursuant to the liquidation of the Stock Award Deferral Program on November 30, 2025 as previously disclosed in Chimera's Annual Report on Form 10-K for the year ended December 31, 2024. |
| F2 | Dividend equivalent rights ("DERs") issued on RSUs and PSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock. |